
	Three Months Ended				Six Months Ended
	June 30, 2026		June 30, 2025		June 30, 2026		June 30, 2025
Net income attributable to shareholders of Criteo S.A.	$	11,190	$	21,250	$	19,007	$	59,178
Weighted average number of shares outstanding of Criteo S.A.	49,664,392		52,986,068		50,007,078		53,480,338
Basic earnings per share	$	0.23	$	0.40	$	0.38	$	1.11

Diluted EPS considers the impact of potentially dilutive shares not yet issued from share-based compensation plans using the treasury stock method. There were no other potentially dilutive instruments outstanding as of June 30, 2026 and 2025. Consequently, all potential dilutive effects from shares are considered.

For each period presented, a contract to issue a certain number of shares (i.e., stock options and nonemployee warrants) was assessed as potentially dilutive if it was “in the money” (i.e., the exercise or settlement price is lower than the average market price).


	Three Months Ended				Six Months Ended
	June 30, 2026		June 30, 2025		June 30, 2026		June 30, 2025
Net income attributable to shareholders of Criteo S.A.	$	11,190	$	21,250	$	19,007	$	59,178
Basic shares:
Weighted average number of shares outstanding of Criteo S.A.	49,664,392		52,986,068		50,007,078		53,480,338
Dilutive effect of:
RSUs and PSUs	881,523		2,089,046		747,496		2,584,404

Stock options	—		31,986		—		57,471
Share warrants	—		26,469		—		40,246
Diluted shares:
Weighted average number of shares outstanding used to determine diluted earnings per share	50,545,915		55,133,569		50,754,574		56,162,459
Diluted earnings per share	$	0.22	$	0.39	$	0.37	$	1.05

The weighted average number of securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future are as follows:


	Six Months Ended
	June 30, 2026	June 30, 2025
Restricted share awards	1,932,175	1,349,639

Weighted average number of anti-dilutive securities excluded from diluted earnings per share	1,932,175	1,349,639